Hollow Brook Wealth Management LLC raised its position in Colgate-Palmolive (NYSE:CL – Free Report) by 5.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,200 shares of the company’s stock after acquiring an additional 200 shares during the period. Hollow Brook Wealth Management LLC’s holdings in Colgate-Palmolive were worth $436,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently modified their holdings of CL. Main Street Research LLC increased its holdings in Colgate-Palmolive by 1.5% in the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after buying an additional 100 shares in the last quarter. Advisor OS LLC lifted its holdings in Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after buying an additional 101 shares in the last quarter. BLB&B Advisors LLC raised its stake in shares of Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after acquiring an additional 104 shares in the last quarter. D Orazio & Associates Inc. grew its position in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares in the last quarter. Finally, ZWJ Investment Counsel Inc. boosted its position in shares of Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after purchasing an additional 109 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.34% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Trading Down 0.1 %
NYSE:CL opened at $96.63 on Monday. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30. The firm has a market capitalization of $78.95 billion, a P/E ratio of 27.69, a PEG ratio of 3.45 and a beta of 0.42. The company’s 50-day simple moving average is $97.38 and its 200 day simple moving average is $98.64. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.07%. Colgate-Palmolive’s payout ratio is 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Upcoming IPO Stock Lockup Period, Explained
- 4 AI-Powered Fintechs Revolutionizing the Future of Finance
- 3 Healthcare Dividend Stocks to Buy
- Ambarella’s Traction Drives Stock Surge: Market Reversal Underway
- Following Congress Stock Trades
- NVIDIA Invested in These 2 AI Stocks, Should You?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.